--- title: "Ausun Pharm released its semi-annual performance report, with a net profit attributable to the parent company of 169 million yuan, a year-on-year decrease of 5.83%" type: "News" locale: "en" url: "https://longbridge.com/en/news/254945684.md" description: "According to the Zhitong Finance APP, Ausun Pharm disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 482 million yuan, a year-on-year decrease of 2.14%; net profit attributable to the parent company was 169 million yuan, a year-on-year decrease of 5.83%; net profit excluding non-recurring gains and losses was 151 million yuan, a year-on-year decrease of 12.29%; basic earnings per share were 0.20 yuan" datetime: "2025-08-28T07:50:05.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/254945684.md) - [en](https://longbridge.com/en/news/254945684.md) - [zh-HK](https://longbridge.com/zh-HK/news/254945684.md) --- # Ausun Pharm released its semi-annual performance report, with a net profit attributable to the parent company of 169 million yuan, a year-on-year decrease of 5.83% According to the Zhitong Finance APP, Ausun Pharm (603229.SH) disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 482 million yuan, a year-on-year decrease of 2.14%; net profit attributable to the parent company was 169 million yuan, a year-on-year decrease of 5.83%; net profit excluding non-recurring gains and losses was 151 million yuan, a year-on-year decrease of 12.29%; basic earnings per share were 0.20 yuan ### Related Stocks - [603229.CN](https://longbridge.com/en/quote/603229.CN.md) ## Related News & Research - [TRUMP ON UFO FILES: WE WILL DECLASSIFY AS MUCH AS POSSIBLE GOING FORWARD.](https://longbridge.com/en/news/284625392.md) - [RFK Jr.'s New Autism Committee Issues First Proposals](https://longbridge.com/en/news/284480897.md) - [](https://longbridge.com/en/news/284610260.md) - [Purdue Pharma to be sentenced, paving way for opioid settlement](https://longbridge.com/en/news/284356869.md) - [07:16 ETChina's Yangtze River Pharmaceutical Group Expands Global Footprint as Quality Drives Growth](https://longbridge.com/en/news/284557182.md)